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REINFORCING EFFICACY OF AMPHETAMINE 
IN ADOLESCENT AND ADULT MALE RATS 
 
by 
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Under the Direction of Kyle J. Frantz 
 
 
ABSTRACT 
 
 Rationale: Amphetamine abuse by adolescents predicts long-term drug 
dependence. Heightened vulnerability to drug abuse could be due to higher sensitivity to  
drug’s reinforcing effects. Rodents are used to study age-related sensitivities to drugs. 
Objective: We compared intravenous amphetamine self-administration between 
adolescent and adult male rats on an operant schedule of reinforcement measuring the 
reinforcing efficacy of a drug. Methods: After surgery, adolescent and adult rats acquired 
lever-pressing behavior reinforced by amphetamine infusions. Results: Both age groups 
exhibited more infusions per session as dose increased. However, neither the number of 
infusions per session nor total amphetamine intake differed across age groups. 
Conclusion: Although rapid transition is reliable to test reinforcing properties of 
stimulants, results suggest that amphetamine is an equally efficacious reinforcer among 
both age groups. In regards to humans, these results suggest that other factors, like social 
influences, explain higher rates of drug intake by adolescent compared with adult humans.    
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Introduction 
 Drug abuse is a problem in the United States. In 2006, 112 million Americans 12 
years and older reported using an illicit drug at least once in their lifetime (SAMHSA 
2005). Specifically, the stimulant amphetamine has remained a popular drug of abuse, 
with 99% of stimulant treatment admissions relating to methamphetamine abuse 
(SAMHSA 2005). Adolescent initiation of drug use predicts long-term drug abuse and 
dependence (Laviola et al. 1999-this reference needs to be a human study, not animal). 
Although not yet reaching the rate of adult illicit drug use, adolescent initiation of 
amphetamine abuse has increased significantly since 1994 (Johnston et al. 2005). These 
statistics require research into factors underlying adolescent vulnerability to illicit drug 
use, abuse, and dependence. 
 Adolescence is a period in development characterized by behavior such as 
increased interest in novelty-seeking, social interactions among peers, and overall “risky 
or reckless” behavior, that spans across species, from humans to nonhuman primates and 
rodents (Adriani et al. 1998; Arnett 1992; Smith 2003; Spear 2000). In specifically 
researching human adolescent drug abuse, perhaps the ideal subjects would be humans; 
however, administering drugs of abuse to humans is unethical. Another experimental 
model of choice would be nonhuman primates, as they are closely related to humans with 
regard to development and behavior; however, they are extremely expensive. Rodents, 
while more removed from humans in terms of species similarities, have been validated as 
good models in behavioral assays related to drugs of abuse (e.g. Ator and Griffiths 2003; 
Laviola et al. 1999; Spear 2000).  
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 Rodent adolescence can be defined as the timeframe from 7-10 days before the 
start of puberty through the first few days afterward [Post Natal Days (PND) 35-55]. 
Behavioral characteristics often displayed by adolescent rodents include increased 
novelty-seeking and increased time spent in social interactions compared with younger 
and older rodents (Adriani et al. 1998; Izenwasser 2005; Spear 2000; Smith 2003). 
Despite these similarities to adolescent humans, adolescent rodents have not been used 
extensively for research on vulnerability to drugs of abuse. 
 Drug-related behavioral reinforcement paradigms are often used to investigate the 
reinforcing potency and efficacy of a stimulus. Reinforcing stimuli can include food, 
alcohol, and intravenous (i.v) drug infusions. More specifically, i.v. drug self-
administration in rats models some aspects of drug abuse in humans (Ator and Griffiths 
2003; Caine et al. 1993; Richardson and Roberts 1996). In this model, operant behavior 
(lever-pressing) is reinforced by i.v. drug infusions.  The test subjects control their drug 
intake during the test sessions. Two well-validated schedules of reinforcement are Fixed 
Ratio (FR) and Progressive Ratio (PR). FR is a simple schedule in which a rat must make 
a set number of lever presses to receive each drug infusion. FR is a straightforward 
method for animals to acquire self-administration, and a dose-effect function which 
contains both an ascending and descending limb usually results from FR studies (Fig 1; 
Green et al. 2002).  
  An alternative to FR is the PR schedule, in which the number of presses required 
to obtain each drug infusion increases gradually during a single session; this forces the 
subject to meet increasing behavioral demands throughout the session to obtain the drug. 
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This is a more reliable approach than FR to measure reinforcing efficacy of a stimulant, 
because it allows for easier interpretation of results identified in the PR monotonic dose-
effect function (Fig. 1; Green et al. 2002). In addition, PR uses breakpoint to interpret 
drug reinforcing efficacy. By definition, breakpoint is the highest ratio of lever presses to 
drug infusion a subject completes before quitting. Thus, rats generally control their 
individual PR session durations, as sessions stop when rats quit responding for a certain 
length of time (e.g. 60 min; Suto et al. 2002, 2003). Breakpoint cannot be analyzed 
statistically, however, due to its establishment from an exponential function. Ratios at the 
high end of the scale will have larger variance than values at the low end of the scale, 
possibly masking group differences (Richardson and Roberts 1996). Therefore, the 
number of infusions per session is analyzed, as in an FR session.   
 A previous project from our group compared age and sex differences in 
amphetamine self- administration by adolescent and adult Sprague-Dawley rats 
(Shabhazi et al. 2007). Acquisition was tested on an FR schedule for 14 days, and 
adolescent males received more drug infusions than adult males on a 0.05 mg/kg/infusion 
amphetamine dose. Higher rates of lever pressing in adolescents vs. adults suggest 
adolescent hypersensitivity to amphetamine’s reinforcing effects, i.e. they might 
represent an upward shift in the dose-effect function (Fig. 2; Piazza et al. 2000). An 
alternative interpretation is that adolescents are less sensitive to the reinforcing effects of 
amphetamine; higher rates of pressing maintained by lower amphetamine doses could be 
part of a rightward shift in the typical dose-effect function. These conflicting 
interpretations of FR results have led to the use of alternative schedules, such as the PR 
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schedule of reinforcement outlined above. Its monotonic dose-effect function is likely to 
produce clearer results than FR, therefore, the present study used a PR schedule to 
compare amphetamine’s reinforcing efficacy in adolescent vs. adult male rats. On the 
present PR schedule, higher infusions per session would support the first interpretation of 
the Shabhazi et al. (2007) study, whereas lower infusions per session would support the 
second interpretation (Fig. 3).  
 Based on previous studies that have reported hyposensitivity to amphetamine 
among adolescent rodents (Adriani and Laviola 2003; Bolanos et al. 1998), we predicted 
adolescent rats would be less sensitive to amphetamine’s reinforcing effects than adults, 
therefore taking fewer drug infusions than adults on the PR schedule of reinforcement. In 
order to test adolescent rats on PR during adolescence, we used a rapid transition FR to 
PR protocol, as per the Suto et al. 2002, 2003 studies. FR was first used to facilitate the 
association between behavior (lever press) and consequence (drug infusion) in this 
operant conditioning model. After FR criteria were met, subjects transitioned to a PR 
schedule for the remainder of the study. Three amphetamine doses (0.00, 0.05, and 0.2 
mg/kg/infusion) were tested on PR; thus, subjects that acquired self-administration within 
the initial 5 days of testing on FR1 and FR2 schedules during adolescence (PND 35) or 
adulthood (PND 85-88) at start of testing were tested on a PR schedule during late 
adolescence (PND 42 and beyond) or older adulthood (PND 92 and beyond). Results 
from this assay should reveal age differences in amphetamine’s reinforcing efficacy in 
male rats. 
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Figure 1. Sample dose-effect functions from fixed ratio and progressive ratio schedules of 
reinforcement in amphetamine self-administration by adult rats (Green et al. 2002). 
Fixed Ratio (FR) Schedule of Reinforcement 
Progressive Ratio (PR) Schedule of Reinforcement 
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Figure 2. Number of infusions per session during acquisition of lever-pressing maintained 
by 0.05 mg/kg/infusion amphetamine on a fixed ratio 1 schedule of reinforcement 
(Shahbazi et al. 2007). 
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Figure 3.    Possible interpretations of FR results from Shahbazi (2007) on fixed 
ratio schedule of reinforcement, and potential resolution by testing on progressive 
ratio schedule of reinforcement 
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Materials and Methods 
 
Subjects 
 Sixteen male Sprague-Dawley rats (Charles River Laboratories, Wilmington, MA) 
arrived in the laboratory at either PND 22 (adolescents) or PND 72 (adults).   Rats were 
housed in groups of 2-3 in a humidity and temperature-controlled vivarium (20-22˚C), on 
a 12/12 hr light/dark cycle (lights turned off at 0500 or 0600 h).  Subjects acclimated one 
week before experimentation and had access to food and water ad libitum throughout the 
study except during behavioral test sessions.  Beginning two days after arrival, rats were 
weighed and handled daily by the experimenters.  Body weights for all rats gradually 
increased throughout the experiment, suggesting no adverse drug effects on physical 
health.  All procedures followed the Guidelines for the Care and Use of Mammals in 
Neuroscience and Behavioral Research (NRC 2003). 
 
Drugs 
 d-Amphetamine sulfate salt was purchased from Sigma Chemicals (St. Louis, 
MO).  Amphetamine stock solutions were diluted with saline for drug dose titration based 
on body weight. The drug was titrated each time a rat gained 10 g or more (usually every 
1-2 days). Methohexital sodium (1% Brevital Sodium) was purchased from King 
Pharmaceuticals, Inc. (Bristol, TN). Both amphetamine and Brevital solutions were 
filtered with 25µm syringe filters (Fisher Scientific, Hampton, NH). 
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Equipment 
 Intravenous (i.v) catheters for self-administration were made in the lab, as 
previously described (Caine et al. 1993; Shabhazi et al. 2007).  Briefly, catheters were 
assembled from metal guide cannulae bent at a right angle and fitted with 14-cm lengths 
of silastic tubing stretched over the cannulae.  Polypro mesh was cut into 3-cm diameter 
circles and secured to the guide cannula assembly with methylmethacrylate. Tissue 
growth around the mesh secured the catheter in place after implantation.  
 The self-administration equipment included operant boxes enclosed in sound-
attenuating, ventilated cubicles (Med Associates, Inc., St. Albans, VT). Presses on an 
active lever triggered a syringe pump with a 6 rpm motor to deliver 0.1 ml of drug 
solution (Med Associates, Inc., St. Albans, VT) over 2 sec via a stainless steel swivel and 
a polyethylene tube attached to the catheter portal on the rat’s back.  Each reinforced 
response lit a cue light above the active lever, which remained lit throughout the infusion.  
The cue light, house light, and white noise were not present during a 10 s time-out (TO) 
after infusion delivery.  Progressive ratio (PR) testing included two levers.  Lever 
pressing during TO and presses on the inactive lever were recorded but did not result in 
any scheduled consequences.  Drug delivery and data collection were controlled by Med 
Associates, Inc. software (Med PC IV). 
 
Surgical Procedures 
 Catheters were implanted into the rat as previously described (Caine et al. 1993, 
Shabhazi et al. 2007).  Briefly, rats were anesthetized with an isofluorane/oxygen vapor 
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mixture (4-5% for initial anesthetization and 1.5-3% during surgery) while catheter 
tubing was passed subcutaneously from the subject’s back to the right jugular vein.  The 
tubing was inserted into the vein previously punctured with a 25 gauge needle, and tied 
carefully with suture thread.  During post-surgical recovery, rats received 1.5-2.0 ml 
Timentin antibiotic (Ticarcillin Disodium and Clavulanate Potassium; 100 mg/ml, i.v.) 
twice daily on the first two days post-surgery, then once daily after each session 
throughout the experiment.  Catheters were also flushed daily with 1.5-2.0 ml heparinized 
saline (100 USP units/1ml) pre- and post- session.   Catheters were flushed with 0.1-0.4 
ml of Brevital sodium (1% methohexital sodium) weekly during testing to ensure i.v. 
catheter patency.  If muscle tone was not lost within 5s, the catheter was concluded to be 
defective and the subject’s data were not included in the analyses. Four rats failed this 
Brevital test, leaving twelve subjects in most of the data analysis to follow. 
 
Acquisition of Self-Administration on a Fixed Ratio (FR) Schedule of Reinforcement 
 After four to seven-day post-surgical recovery, rats were tested for spontaneous 
acquisition of amphetamine self-administration (PND 35 or PND 85-88 at start) on a 
protocol modeled after the methods of Lorrain and Vezina (1999).  A rapid transition 
from FR to PR schedules of reinforcement was performed in order to ensure adolescent 
rats began PR testing during the adolescent period, which is generally defined as PND 
35-55.  (See Fig. 4 for a timeline of experimentation.)  During FR1, rats received a single 
i.v. priming infusion of 0.2 mg/kg amphetamine at the start of each session, and sessions 
ceased immediately after a subject satisfied the criterion of obtaining at least an 
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additional 10 infusions, or 2 h elapsed, whichever came first.  After FR1, rats proceeded 
to an FR2 schedule, in which 2 lever presses were required to receive one i.v. drug 
infusion.  Both FR1 and FR2 sessions began with 1 lever extended into the operant 
chamber and a house light and white noise turned on.  Lever-pressing was reinforced by 
an i.v. infusion of 0.2 mg/kg/0.1 ml amphetamine over 2 s. A cue light above the lever 
remained on during the infusion, followed by a 10 s timeout (TO) during which the cue 
light, white noise, and house light remained off.  
  The FR2 criterion of at least 10 additional infusions (after the priming infusion) 
during the 2 h session was required for a subject to move to PR testing.  Rats that 
satisfied both the FR1 and FR2 criteria within the initial 5 days of testing were then 
moved to a PR schedule for the remainder of the study.   FR1 and FR2 were used to 
provide a simple method for subjects to acquire the self-administration behavior prior to 
challenge with the more complex PR schedule.  An amphetamine dose of 0.2 mg/kg was 
chosen for the FR phase after extensive pilot work with various doses and because 
previous studies have reported this dose as sensitizing and reinforcing in rats (Vezina et 
al. 2002; Lorrain and Vezina 2000). 
 
PR Testing 
 On the PR schedule, the number of responses required to obtain each drug 
infusion increased gradually within the session, according to an exponential ratio: 1, 3, 6, 
9, 12, 17, 24, 32, 42, 56, 73, 95, 124, 161, 208 (Roberts et al. 1989).  The daily PR 
sessions lasted for a maximum of 6 h, or until 1 h elapsed without a drug infusion. The 6 
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h session length was used to prevent early termination of the session prior to the rat 
ceasing its drug-seeking behavior.  During PR (but not FR) conditions, a second, inactive 
lever was extended into the chamber but no priming infusions were given; other 
parameters (cues, TO) in PR remained the same as FR. 
 PR testing was initiated using either 0.05 or 0.2 mg/kg/infusion amphetamine 
doses for 5 consecutive days.  Rats were divided into two dose groups counterbalanced 
for infusions obtained during the first few days of PR testing. In the following week, 
saline substitution was tested (see below).  In the third and final week of testing, the 
alternate amphetamine dose was tested.  Each test phase was separated by a two-day 
recess, including a Brevital test for catheter patency on the second day.  
 
Saline Substitution 
 Saline substitution was inserted between weeks of amphetamine testing, in part to 
determine whether lever-pressing behavior was maintained by amphetamine in the weeks 
prior and subsequent to saline substitution.  Saline was tested on the same PR schedule as 
amphetamine. 
 
Data Analysis and Statistics 
Changes in body weight were analyzed in a two-way ANOVA, with cohort x days 
as factors. The two cohorts analyzed were rats that acquired self-administration in the 
present study and rats that did not acquire self-administration from Shabhazi et al. (2007) 
for comparison. Days to reach criterion on FR1 and FR2 were analyzed in a two-way 
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analysis of variance (ANOVA), with age x schedule as factors. The number of drug 
infusions, session duration, and lever discrimination on PR testing were averaged over 
the last four days of testing at each dose for each rat, and total amphetamine intake was 
summed over the last four days of testing at each dose. The number of drug infusions per 
session as well as session durations were analyzed using two-way ANOVAs with dose x 
age as factors. A three-way ANOVA was performed on lever presses (active vs. inactive 
lever presses), with dose x lever x age as factors. Breakpoints are indicated with infusions 
per session on graphs, but are not statisticall analyzed (see Introduction).  Active lever 
presses were presses on the active lever that led to drug infusions, whereas inactive 
presses were on the inactive lever that did not advance the rat toward obtaining another 
infusion.  Follow-up one-way ANOVAs and post-hoc tests (pairwise t-tests) were 
conducted as appropriate for each dependent variable.    
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Figure 4.  Timeline of experimentation.  
Arrive in lab Surgical 
implantation 
of catheter 
and recovery 
6 13 
Rapid Transition 
FR1→FR2→PR 
20Day 
Dose 1
1 
PR Testing → 
Dose 2 
27 34 
Saline  
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Results 
 
Changes in Body Weight in Acquired vs. Non-Acquired Rats 
 Body weight increased at a similar rate among rats that acquired self-
administration in this study and those that did not acquire self-administration (from 
Shabhazi et al. 2007; Fig. 5). However, body weight differed throughout acquisition 
testing between adult acquired vs. non-acquired rats. A two-way ANOVA on body 
weight among adult acquired vs. non-acquired rats, with cohort x days as factors, 
revealed a main effect of cohort [F(1,12)= 13.16, p=0.003] and days [F (9,108)= 17.46, p< 
0.01 ]; however, the cohort x days interaction [F(9,108)= 1.97, p=0.05] was not significant.  
The difference in acquired and non-acquired adults is likely due to the different initial 
weights between groups. Among adolescent rats, a main effect of days [F(9,72)=146.46, 
p<0.01] and cohort x days interaction [F(9,72)= 4.07, p<0.01] suggested gradual weight 
gain, but it did not differ by cohort [F(1,8)<0.001, p=0.95]. 
 
Rates of Acquisition on FR1 and FR2 
 Adolescent and adult rats reached criterion levels of pressing on FR1 and FR2 at 
approximately the same rate (Fig. 6). A two-way ANOVA on the number of days 
required to reach criterion levels of pressing on each successive schedule  revealed no 
significant main effects of schedule [F(1,15)=1.18, p=0.30] or age [F(1,15)=0.39, p=0.54], 
nor was the schedule x age interaction significant [F(1,15)=0.35, p=0.57].  
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Infusions Per Session on PR Schedule 
 Infusions per session on the PR schedule increased with dose per infusion, but did 
not vary by age (Fig. 7 and 8). A two-way ANOVA with dose x age as factors, number of 
infusions being the dependent measure, revealed a significant main effect of dose 
[F(2,20)=8.38, p=0.002], but neither the main effect of age [F(1,10) = 0.018, p=0.90], nor a 
significant dose x age interaction was significant [F(2,20)=0.52, p=0.60]. These statistics 
were calculated using only rats that were tested on all doses (0.00, 0.05, and 0.2 
mg/kg/infusion; n= 5 adolescents and n= 7 adults). A follow-up one-way ANOVA and 
paired t-tests on the dose factor revealed that rats took more infusions at the 0.05 or 0.2 
mg/kg/infusion doses compared with saline (p<0.05), and more infusions at 0.2 compared 
with 0.05 mg/kg/infusion as well. 
 
Total Amphetamine Intake During PR Testing 
 Total amphetamine intake increased with dose per infusion, but did not vary by 
age (Fig. 9).  A 2-way ANOVA with dose x age as factors, total intake being the 
dependent measure, revealed a significant main effect of dose [F(1,10)=23.64, p=0.01], but 
no main effect of age [F(1,10)=0.66, p=0.43], nor a significant interaction between dose and 
age [F(1,10)=0.73, p=0.40].  
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Active vs. Inactive Lever Presses 
 Presses on the active lever outnumbered inactive lever presses on all doses, and 
active lever presses increased as dose increased. However, no age difference in active or 
inactive presses was identified (Fig. 10). Thus, a three-way ANOVA with dose x age x 
lever type as factors, lever presses being the dependent measure, revealed a significant 
main effect of dose [F(2,20) =4.48, p=0.025] and response type [F(1,10) =5.50, p=0.041], as 
well as a significant dose x response interaction [F(2,20)=4.32, p=0.028], but no main 
effect of age [F(1,10)=0.35, p=0.57], nor interactions between dose x age [F(2,20)= 0.16, 
p=0.85] or response x age [F (1,10)=0.41, p=0.54]. Follow-up tests revealed that active 
lever presses increased as the dose increased, whereas presses on the inactive lever did 
not differ by dose. Moreover, significant discrimination between active and inactive 
responding occurred at all amphetamine doses.   
 
Session Duration 
 PR session duration did not differ by dose or age (Fig. 11). A two-way ANOVA 
with age x dose as factors, session duration being the dependent measure, revealed no 
significant main effect of dose [F(2,20)=1.92, p=0.17], age [F(1,10)= 2.21, p=0.17], nor a 
significant dose x age interaction [F(2,20)=0.61, p=0.55]. 
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Figure 5.  Body weight increased over days in experimentation for adolescent and adult 
male rats, similarly in rats that did vs. did not reach acquisition criteria by day 10. [All 
rats that did not reach acquisition criteria derived from a separate experiment (Shahbazi 
et al. 2007)].  Values are mean ± SEM. A significant main effect of adult cohort is 
indicated (**p<0.01).   
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Figure 6.  Adolescent and adult rats reached the criterion number of presses on FR1 and 
FR2 schedules at approximately the same rate.  Bars represent mean ± SEM days on each 
schedule before moving to the next schedule (see Methods).   
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Figure 7.  Average number of infusions for individual adolescent and adult rats, over the 
last four self-administration sessions at each amphetamine dose.   
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 Figure 8.  Average number of infusions for adolescent and adult rats, over the last four 
self-administration sessions at each amphetamine dose.  Bars represent mean ± SEM.  
Only those rats that self-administered all doses are included.  Significant differences from 
saline conditions (0 mg/kg/infusion; * p<0.05, **p<0.01) and the low amphetamine dose 
(0.05 mg/kg/infusion; +p<0.05) are indicated.    
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Figure 9.  Total amphetamine intake (mg/kg) summed over the last four sessions at each 
amphetamine dose.   Bars represent mean ± SEM.  Only those rats that self-administered 
all doses are included.  Significant main effects of dose are indicated (**p<0.01).    
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Figure 10.  Active vs. inactive lever-presses per session averaged over all sessions at each 
amphetamine dose.  Bars represent mean ± SEM.  Significant differences between levers 
are indicated at each dose (# p<0.05, ## p<0.01), along with differences between active 
lever-presses across doses (*p<0.05 different from saline; +p<0.05 different from 0.2 
mg/kg/inf).  Presses did not vary by age.  Only those rats that self-administered all doses 
are included 
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Figure 11.  Duration of self-administration sessions averaged over the last four sessions at 
each amphetamine dose.  Bars represent mean ± SEM.  Only those rats that self-
administered all doses are included.   
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Discussion 
 The present results suggest that amphetamine’s reinforcing effects are similar in 
adolescent and adult male rats in the i.v drug self-administration model. On a PR 
schedule of reinforcement, both age groups demonstrated the expected dose-effect 
function, with maximal number of infusions increasing as amphetamine dose increased 
(Green et al. 2002; Vezina et al. 2002). Similarly, total amphetamine intake increased 
with amphetamine dose. However, neither measure differed by age group. These data do 
not support the hypothesis of adolescent hyposensitivity to amphetamine reinforcement. 
The data could suggest that previously reported age differences in response to 
amphetamine do not extend to reinforcing efficacy. 
 Even though few studies have reported i.v. drug self-administration in adolescent 
rats ( Belluzi et al. 2005, Frantz et al. 2006; Shabhazi et al. 2007), several aspects of the 
current study assist in validating this rapid transition FR-PR method as effective in 
identifying the reinforcing efficacy of a drug during adolescence. First, this protocol 
supported the expected dose-dependent responding in three different cohorts (n=16 rats). 
The dose-effect function exhibited on the PR schedule corresponds to other reports of a 
monotonic dose-effect function on PR, with number of infusions and total drug intake 
received increasing as dose increases (Green et al. 2002; Vezina et al. 2002). Second, the 
maximal infusions received in this study were similar to maximal infusions obtained in 
the Green et al. 2002 study. Third, the lower infusions taken during saline substitution in 
comparison to infusions during the two amphetamine doses help to validate the assertion 
that responding on the PR schedule was maintained by amphetamine (Arnold and Roberts, 
26 
1997; Shabhazi et al. 2007). Fourth, clear active vs. inactive lever discrimination was 
observed in both adolescents and adults on all three test doses, suggesting that subjects 
made efficient associations between levers and drug availability. Finally, gradual 
increases in body weight in both age groups in the present study indicated that the health 
of the rats was maintained throughout the experiment. Therefore, the present results are 
generally in agreement with previous amphetamine and cocaine studies reporting that the 
rapid transition FR-PR is an effective method of reinforcing self-administration in rats 
(Lorrain and Vezina 2000; Suto et al. 2002, 2003). 
 The present results contrast outcomes from Shabhazi et al. (2007). In the prior 
study, adolescent and adult male rats acquired self-administration on FR over 14 
consecutive days, and adolescents took more infusions than adults on the 0.05 
mg/kg/infusion amphetamine dose. Two possible interpretations emerged. First, 
adolescents could be more sensitive to the reinforcing effects of amphetamine, suggested 
if the increased amphetamine intake by adolescents is part of an upward shift in the dose-
effect function (Piazza et al. 2000). Second, adolescents could be less sensitive to the 
reinforcing effects of amphetamine, suggested if the increased intake is part of a 
rightward shift in the dose-effect function.  On the present PR schedule, higher infusions 
per session would support the first interpretation, whereas lower infusions per session 
would support the second. In fact, the complete lack of age differences in the present PR 
study failed to support either interpretation. If validated in future replications of this 
experiment (see below), these results imply that adolescents will take more amphetamine 
than adults if response requirements are “easy”, but that they demonstrate adult levels of 
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intake if behavioral demands are higher (e.g. on a PR schedule).  Alternatively, these 
results could indicate that higher rates of amphetamine intake by adolescents on the FR 
schedule could be mediated by general motor activation rather than increased goal-
directed behavior (see next; Adriani et al. 1998; Collins et al. 2004).   
Motor activation comes into question when interpreting the Shabhazi results, as 
the observed age differences could be due to generalized motor activation among 
adolescents when compared to adults after exposure to amphetamine, which has been 
reported in several previous studies (Adriani et al. 1998; Collins et al. 2004). However, 
other studies have indicated lower locomotor activation and neurochemical sensitivity in 
adolescents after exposure to amphetamine or its derivatives (Laviola et al. 1999; 
Bolanos et al. 1998; Kokoshka et al. 2000). Moreover, qualitative visual analysis of video 
recordings of a representative rat from each age group in the present study suggests no 
age difference in locomotor activity after exposure to amphetamine. Overall, further 
investigation into the motor and neurochemical effects of amphetamine could help to 
interpret the Shabhazi study as well as current results. 
The present results are consistent with other elements of the Shabhazi report and 
several experiments showing similar amphetamine-induced behavior in adolescent and 
adult subjects. The Shabhazi study reported no age difference between male rats in the 
number of infusions on the FR schedule at a lower amphetamine dose (0.025 
mg/kg/infusion). Likewise, other studies have identified no age differences in response to 
amphetamine or other psychomotor stimulants, such as cocaine (Adriani et al 1998; 
Andersen et al. 2001; Frantz et al. 2006; Shram et al. 2007). Altogether the literature on 
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adolescent sensitivity to amphetamine is mixed, suggesting that adolescent vulnerability 
to stimulants is a complex issue.   
 Several limitations of the present method should be considered. First, although the 
rapid transition FR-PR method did produce the expected dose-dependent responding on 
PR, some rats never acquired stable lever-pressing behavior on this schedule. Out of 61 
rats tested on the rapid transition protocol, eight adults and five adolescents did not 
acquire lever-pressing behavior and did not advance from FR to PR. In addition, out of 
six cohorts tested on variations of the rapid transition schedule (varying amphetamine 
dose, time-out and session durations, priming infusions, etc.), only the three cohorts 
reported at present (n=12 rats) demonstrated the expected dose-dependent responding. 
These results suggest that the rapid transition schedule may produce only tenuous 
associations between lever-pressing and i.v amphetamine infusions. Moreover, active 
lever presses during infusions and timeouts were not recorded. Shabhazi et al. (2007) 
reported higher timeout presses in adolescents, which could indicate high impulsivity and 
lower behavioral control by environmental stimuli (Laviola et al. 1999; Adriani and 
Laviola 2003). However, visual analysis of a representative adolescent and adult rat in 
the present study showed little pressing in either rat during infusions and timeouts, 
suggesting that timeout presses were not common throughout the experiment.      
  Another methodological concern is that infusion volume remained constant for 
all rats throughout the study. Amphetamine doses were titrated for each animal based on 
body weight by changing the concentration of drug solution, while infusion volume (0.1 
ml) remained constant. Therefore, the higher volume to body weight ratio in adolescents 
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compared with adults could exert unknown aversive effects on adolescents. Nevertheless, 
current studies in our lab involving cocaine self-administration (Li et al. 2007) indicate 
no effect of titration method on either age group self-administering cocaine. Finally, five 
adolescent and seven adult rats successfully completed testing on all amphetamine doses 
for the present study, which is a low sample size and leads to very low statistical power 
of analysis. Coupled with high variability in lever-pressing among individual animals, the 
data collected with such low subject numbers could be inconclusive, as a small sample 
size could fail to show real age differences in self-administration on the PR schedule.   
 The present lack of age differences in amphetamine reinforcement is surprising in 
light of the major developmental changes in brain reinforcement circuitry that occur 
during adolescence in rats (as well as primates). Some of the structural and 
neurochemical changes in the mesocorticolimbic system during adolescence include a 
several-fold increase in dopamine receptor density (that undergoes pruning prior to 
adulthood) and an increase in dopamine transporter density in the striatum (that 
subsequently decreases through old age; Izenwasser 2005). Previous studies reporting 
amphetamine and other psychomotor stimulant effects on this circuit have shown that 
these drugs stimulate dopamine levels in the nucleus accumbens, which should affect 
general motor behavior as well as responding reinforced by the drug (e.g. Frantz et al. 
2006). However, motor and reinforcing properties of amphetamine can be dissociated 
from each other (Cirulli and Laviola 2000). Therefore, although there are structural 
differences between adolescents and adults in the brain regions thought to underlie both 
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motor activity and behavioral reinforcement (e.g. nucleus accumbens), these differences 
could change motor activity but not reinforcing efficacy of amphetamine. 
 Future research may clarify the current findings. First, the present test on the 
rapid-transition FR-PR schedule should be replicated to increase the sample size and 
confirm the lack of age differences between adolescents and adults. In addition, other 
group comparisons (e.g. young adults, senescent adults, strains, and sex) could be tested 
on this schedule to determine whether the present results generalize to broader rodent 
models, as other studies have reported sex (Shabhazi et al. 2007) and rat strain 
differences in drug self-administration (Shram et al. 2007). Finally, if the rapid-transition 
schedule continues to produce tenuous associations between behavior and reinforcers, 
then the self-administration protocol may need to be modified to allow rats to train longer 
on FR prior to moving to PR. This could include increasing the number of daily FR 
sessions for each rat, or PR session duration (to ensure stable self-administration training 
in the operant paradigm on FR, or avoid early termination of the rat’s motivation to 
obtain an infusion during PR). 
 Overall, rodents appear to be good behavioral models for some aspects of human 
drug-related behavior, and the progressive ratio schedule of reinforcement appears to 
define the reinforcing efficacy of a drug. To the extent that results from studies using 
animal models can be applied to the human condition, the current study suggests that 
adolescents are just as vulnerable as adults to the reinforcing effects of amphetamine. 
Coupled with poor decision-making, extended amounts of leisure time, new access to 
money, and an increase in the influence of peers on behavior that can occur during human 
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adolescence, effective behavioral reinforcement by amphetamine may make teenagers 
more likely than adults to initiate drug intake and progress toward drug dependence. As is 
the case for all measures of animal behavior, individual variability related to genes and 
environment is likely to influence decisions regarding drug use or abuse during both 
adolescence and adulthood.    
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